Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 82009-004, ATORVASTATIN CALCIUM, tablet, film coated, from Quallent.

Product NDC
82009-004
Status
Listed
Labeler
Quallent
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090548
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE80 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
82009-004-10820090004101000 TABLET, FILM COATED in 1 BOTTLE (82009-004-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f00a83aa-3f1d-566d-b9bb-f396f22a27cb
  • NADAC price for package 82009000410

    GET /v1/drugs/nadac/82009000410

Use it

Look up 82009-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.